Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Public ClinicalTrials.gov record NCT00039611. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Oxaliplatin (NSC 266046) in Combination With 5-Fluorouracil and Leucovorin (FOLFOX4) for Patients Who Have Not Received Prior Chemotherapy for Advanced Colorectal Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Clinical trial to study the effectiveness of combination chemotherapy in treating patients who have advanced colorectal cancer.
Study identification
- NCT ID
- NCT00039611
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 15 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2002 (Type not available)
- Primary completion
- Not listed
- Completion
- Oct 2007 (Actual)
- Last update posted
- Jun 20, 2013
2002 – 2007
United States locations
- U.S. sites
- 19
- U.S. states
- 19
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anchorage Oncology Centre | Anchorage | Alaska | 99508 | — |
| Mayo Clinic Scottsdale | Scottsdale | Arizona | 85259 | — |
| University of California San Diego Cancer Center | La Jolla | California | 92093-0658 | — |
| Yale Comprehensive Cancer Center | New Haven | Connecticut | 06520-8028 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Atlanta Cancer Care | Atlanta | Georgia | 30342 | — |
| Cancer Center of Kansas - Wichita | Wichita | Kansas | 67214 | — |
| Louisiana State University School of Medicine | New Orleans | Louisiana | 70112 | — |
| Cancer Therapy Evaluation Program | Bethesda | Maryland | 20852 | — |
| Mayo Clinic Cancer Center | Rochester | Minnesota | 55905 | — |
| St. Vincent Hospital and Health Center | Billings | Montana | 59107-5200 | — |
| Southern Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | — |
| Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| NYU School of Medicine's Kaplan Comprehensive Cancer Center | New York | New York | 10016 | — |
| Lineberger Comprehensive Cancer Center, UNC | Chapel Hill | North Carolina | 27599-7295 | — |
| Ireland Cancer Center | Cleveland | Ohio | 44106-5065 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00039611, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 20, 2013 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00039611 live on ClinicalTrials.gov.